Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375148 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
Potent inhibitors of the mammalian target of rapamycin (mTOR) which contain the triazine scaffold and the (R)-3-methyl morpholine moiety have been identified. Such compounds also demonstrated good selectivity over the related lipid kinase PI3Kα. Incorporation of additional functionality at the 4-position of the arylureidophenyl ring resulted in compounds with enhanced cellular activity.
Graphical abstractPotent inhibitors of the mammalian target of rapamycin (mTOR) which contain the triazine scaffold and the (R)-3-methyl morpholine moiety have been identified. Such compounds also displayed excellent cellular activity and good selectivity over the related lipid kinase PI3Kα.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
David J. Richard, Jeroen C. Verheijen, Ker Yu, Arie Zask,